FDA Due Dilligenc​e Review

Congratulations, you sold or are planning to sell your company. Whether that’s a medical device, drug, food, dietary supplement or cosmetic company, you need to prepare for an FDA due diligence review. An FDA due diligence review is an opportunity for the buyer to review your company’s regulatory compliance, compliance history, and regulatory risk exposure, i.e., how likely is FDA enforcement action.

FDA due diligence involves three primary areas. They are:

  • Pre-market compliance;
  • Labeling; and
  • Post-market compliance.

Pre-market compliance can include a range of activities. For a food or dietary supplements, this often focuses on ingredient compliance, in particular, whether an ingredient is GRAS (generally recognized as safe) or is a New Dietary Ingredient. It could also focus on Food Facility Registrations, Food Canning Establishment registrations, and/or SIDs (process filings). For cosmetics, often the main focus is on color additives. Medical devices and drugs can be the most involved, including an assessment of classification, any pre-market application exemptions claimed, the status of any pre-market applications, and any modifications. It would also include any registrations, including three-part drug registration and registration of any contract manufacturers.

Labeling in any product category is more than the physical packaging but can extend to websites, social media, testimonials, paid reviews, and videos. Even Amazon reviews still pose a risk and merit review. A label review for each product category is looking for different issues but is key to any FDA due diligence review.

Post-market compliance focuses on GMPs or Good Manufacturing Practices. GMPs aren’t just for manufacturers but any private labeling who should be auditing suppliers, tracking complaints, and maintaining procedures for recalls and reporting.

An FDA due diligence review is a multi-factor analysis that is specific to each company. Given the potential depth and complexity, it’s important to plan ahead.

FDA FY 2015 USDA FSIS Budget Appropriations Priorities

FDA Due Diligence Review

Share this:
Posted in , and tagged with
Marc Sanchez

Marc Sanchez

Marc is dedicated to helping his clients navigate the complex world of FDA and USDA legislation. He represents FDA-regulated companies in the food, dietary supplement, beverage, cosmetic, medical device, and drug industries.

Marc is the author of two textbooks and a lecturer at Northeastern University. He is a member of the Washington State Bar Association and the D.C. Bar Association.

Leave a Comment

You must be logged in to post a comment.

Are you in trouble with the FDA?

Don’t panic — you’ve got backup. Download 5 Tips to Help You Navigate FDA Enforcement and learn how to resolve the situation right now.

Expert knowledge of FDA regulations that helps you strategically grow your business